These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 15910628

  • 1. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes.
    Petrova NL, Foster AV, Edmonds ME.
    Diabet Med; 2005 Jun; 22(6):756-61. PubMed ID: 15910628
    [Abstract] [Full Text] [Related]

  • 2. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
    Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR, Donohoe M, Foster AV, Edmonds ME, Boulton AJ.
    Diabetologia; 2001 Nov; 44(11):2032-7. PubMed ID: 11719835
    [Abstract] [Full Text] [Related]

  • 3. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy.
    Gough A, Abraha H, Li F, Purewal TS, Foster AV, Watkins PJ, Moniz C, Edmonds ME.
    Diabet Med; 1997 Jul; 14(7):527-31. PubMed ID: 9223389
    [Abstract] [Full Text] [Related]

  • 4. A prospective study of calcaneal bone mineral density in acute Charcot osteoarthropathy.
    Petrova NL, Edmonds ME.
    Diabetes Care; 2010 Oct; 33(10):2254-6. PubMed ID: 20628091
    [Abstract] [Full Text] [Related]

  • 5. Calcaneal ultrasonometry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover.
    Jirkovská A, Kasalický P, Boucek P, Hosová J, Skibová J.
    Diabet Med; 2001 Jun; 18(6):495-500. PubMed ID: 11472470
    [Abstract] [Full Text] [Related]

  • 6. Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: An 8.5-year prospective case-control study.
    Jansen RB, Christensen TM, Bülow J, Rørdam L, Holstein PE, Jørgensen NR, Svendsen OL.
    J Diabetes Complications; 2018 Feb; 32(2):164-170. PubMed ID: 29196119
    [Abstract] [Full Text] [Related]

  • 7. Asymmetrical attenuation of vibration sensation in unilateral diabetic Charcot foot neuroarthropathy.
    Valabhji J, Marshall RC, Lyons S, Bloomfield L, Hogg D, Rosenfeld P, Gabriel CM.
    Diabet Med; 2012 Sep; 29(9):1191-4. PubMed ID: 22276944
    [Abstract] [Full Text] [Related]

  • 8. The effect of polyneuropathy on foot microcirculation in Type II diabetes.
    Nabuurs-Franssen MH, Houben AJ, Tooke JE, Schaper NC.
    Diabetologia; 2002 Aug; 45(8):1164-71. PubMed ID: 12189447
    [Abstract] [Full Text] [Related]

  • 9. Pressure pain thresholds at the diabetic Charcot-foot: an exploratory study.
    Chantelau E, Wienemann T, Richter A.
    J Musculoskelet Neuronal Interact; 2012 Jun; 12(2):95-101. PubMed ID: 22647283
    [Abstract] [Full Text] [Related]

  • 10. [Diabetic osteoarthropathy of the foot].
    Blaser KU, Aeschlimann A, Gerber B.
    Z Rheumatol; 1990 Jun; 49(4):224-6. PubMed ID: 2238863
    [Abstract] [Full Text] [Related]

  • 11. Plantar pressure distribution in Type 2 diabetic patients without peripheral neuropathy and peripheral vascular disease.
    Pataky Z, Assal JP, Conne P, Vuagnat H, Golay A.
    Diabet Med; 2005 Jun; 22(6):762-7. PubMed ID: 15910629
    [Abstract] [Full Text] [Related]

  • 12. Charcot foot in diabetes: farewell to the neurotrophic theory.
    Chantelau E, Onvlee GJ.
    Horm Metab Res; 2006 Jun; 38(6):361-7. PubMed ID: 16823717
    [Abstract] [Full Text] [Related]

  • 13. Diabetic neuropathy in patients with "latent autoimmune diabetes of the adults" (LADA) compared with patients with type 1 and type 2 diabetes.
    Baum P, Hermann W, Verlohren HJ, Wagner A, Lohmann T, Grahmann F.
    J Neurol; 2003 Jun; 250(6):682-7. PubMed ID: 12796829
    [Abstract] [Full Text] [Related]

  • 14. Influence of diabetes on peripheral bone mineral density in men: a controlled study.
    Bridges MJ, Moochhala SH, Barbour J, Kelly CA.
    Acta Diabetol; 2005 Jun; 42(2):82-6. PubMed ID: 15944841
    [Abstract] [Full Text] [Related]

  • 15. Bone mineral density of both genders in Type 1 diabetes according to bone composition.
    Hadjidakis DJ, Raptis AE, Sfakianakis M, Mylonakis A, Raptis SA.
    J Diabetes Complications; 2006 Jun; 20(5):302-7. PubMed ID: 16949517
    [Abstract] [Full Text] [Related]

  • 16. Recurrence of the acute Charcot foot in diabetes.
    Rudrappa S, Game F, Jeffcoate W.
    Diabet Med; 2012 Jun; 29(6):819-21. PubMed ID: 22587408
    [Abstract] [Full Text] [Related]

  • 17. Relationship between peripheral diabetic neuropathy and microvascular reactivity in patients with type 1 and type 2 diabetes mellitus -- neuropathy and microcirculation in diabetes.
    Kasalová Z, Prázný M, Skrha J.
    Exp Clin Endocrinol Diabetes; 2006 Feb; 114(2):52-7. PubMed ID: 16570233
    [Abstract] [Full Text] [Related]

  • 18. Selective neuropathy and preserved vascular responses in the diabetic Charcot foot.
    Stevens MJ, Edmonds ME, Foster AV, Watkins PJ.
    Diabetologia; 1992 Feb; 35(2):148-54. PubMed ID: 1547919
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes.
    Anaforoglu I, Nar-Demirer A, Bascil-Tutuncu N, Ertorer ME.
    J Diabetes Complications; 2009 Feb; 23(1):12-7. PubMed ID: 18413190
    [Abstract] [Full Text] [Related]

  • 20. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture.
    Chantelau E.
    Diabet Med; 2005 Dec; 22(12):1707-12. PubMed ID: 16401316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.